Dry powder inhaler is a medical device that is used for the effective delivery of medication to the lungs. The medication comes in the form of dry powder. The inhaled therapy in general, and dry powder inhalers in particular are deemed to be well-positioned for capitalizing on these trends, and evolving as major drivers for future development of the pharmaceutical sector, and commercialization of therapeutic drugs related to respiratory disorders.
Rise in incidence of respiratory disorders including chronic obstructive pulmonary diseases and asthma, increase in air pollution levels especially in emerging countries, and surge in per capita health care spending are the major factors increasing demand and consumption of dry powder inhalers worldwide.
Global Dry Powder Inhaler market is segregated on the basis of Application as pulmonary arterial hypertension, asthma, chronic obstructive pulmonary diseases and other diseases. Based on product type, the global Dry Powder Inhaler market is segmented in single dose dry powder and multi dose dry powder. The report also bifurcates global Dry Powder Inhaler market based on distribution channel in online pharmacies, hospital pharmacies, retail pharmacies and drug stores.
Global Dry Powder Inhaler market report provides geographic analysis covering regions such as North America, Europe, Asia Pacific, and Rest of World. The Dry Powder Inhaler market for each region is further segmented for major countries including U.S., Canada, Germany, UK, France, Italy, China, India, Japan, Brazil, South Africa and others.
Competitive Rivalry
3M Company, AstraZeneca Plc, Novartis AG are among the major players in the global Dry Powder Inhaler market share. The companies are involved in several growth and expansion strategies to gain a competitive advantage. Industry participants also follow value chain integration with business operations in multiple stages of the value chain.
The Dry Powder Inhaler Market has been segmented as below:
Dry Powder Inhaler Market, by Application
Dry Powder Inhaler Market, by Product Type
Dry Powder Inhaler Market, by Distribution Channel
Dry Powder Inhaler Market, By Region
The report covers:
Report scope:
Global Dry Powder Inhaler market report scope includes detailed study covering underlying factors influencing the industry trends.
The report covers analysis on regional and country level market dynamics. The scope also covers competitive overview providing company market shares along with company profiles for major revenue contributing companies.
The report scope includes detailed competitive outlook covering market shares and profiles key participants in the global Dry Powder Inhaler market share. Major industry players with significant revenue share include Novartis AG, GlaxoSmithKline Plc, Cipla Ltd. etc.
Reasons to Buy this Report:
Customization:
Customized report as per the requirement can be offered with appropriate recommendations
Below are our new reports:
Exosome Diagnostic and Therapeutics Market
Genital Herpes Treatment Market
Hepatitis B Diagnostic Tests Market
1. Introduction
1.1. Key Points
1.2. Report Description
1.3. Markets Covered
1.4. Stakeholders
2. Research Methodology
2.1. Research Scope
2.2. Research Methodology
2.2.1. Market Research Process
2.2.2. Research Methodology
2.2.2.1. Secondary Research
2.2.2.2. Primary Research
2.2.2.3. Models for Estimation
2.3. Market Size Estimation
2.3.1. Bottom-Up Approach
2.3.2. Top-Down Approach
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Drivers
4.2.1. Increasing in aging population
4.2.2. Increasing in number of chronic diseases
4.3. Restraints
4.3.1. Availability of alternate products
4.3.2. Non resistance of moisture
5. Dry Powder Inhaler Market, By Application
5.1. Key Points
5.2. Pulmonary Arterial Hypertension
5.3. Asthma
5.4. Chronic Obstructive pulmonary Diseases
5.5. Other diseases
6. Dry Powder Inhaler Market, By Product Type
6.1. Key Points
6.2. Single Dose Dry Powder
6.3. Multi Dose Dry Powder
7. Dry Powder Inhaler Market, By Distribution Channel
7.1. Key Points
7.2. Online Pharmacies
7.3. Hospital Pharmacies
7.4. Retail Pharmacies
7.5. Drug Stores
8. Competitive Landscape
8.1. Introduction
8.2. Recent Developments
8.2.1. Mergers &Acquisitions
8.2.2. New Product Developments
8.2.3. Portfolio/Production Capacity Expansions
8.2.4. Joint Ventures, Collaborations, Partnerships & Agreements
8.2.5. Others
9. Company Profile
9.1. Cipla Ltd.
9.1.1. Company Overview
9.1.2. Product/Service Landscape
9.1.3. Financial Overview
9.1.4. Recent Developments
9.2. Novartis AG
9.2.1. Company Overview
9.2.2. Product/Service Landscape
9.2.3. Financial Overview
9.2.4. Recent Developments
9.3. AstraZeneca Plc
9.3.1. Company Overview
9.3.2. Product/Service Landscape
9.3.3. Financial Overview
9.3.4. Recent Developments
9.4. GlaxoSmithKline Plc
9.4.1. Company Overview
9.4.2. Product/Service Landscape
9.4.3. Financial Overview
9.4.4. Recent Developments
9.5. Boehringer Ingelheim GmbH
9.5.1. Company Overview
9.5.2. Product/Service Landscape
9.5.3. Financial Overview
9.5.4. Recent Developments
The Dry Powder Inhaler Market has been segmented as below:
Dry Powder Inhaler Market, by Application
Dry Powder Inhaler Market, by Product Type
Dry Powder Inhaler Market, by Distribution Channel
Dry Powder Inhaler Market, By Region
SUBSCRIBE TO OUR NEWSLETTERS
